Debt increased 67.2%
Debt changed +67.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$176.6M→$295.2M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →BC financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income increased 85.2%
Net income changed +85.2% from the comparable as-filed period.
$59.3M→$109.8M2 prior comparisons
Operating income increased 25.3%
Operating income changed +25.3% from the comparable as-filed period.
$103.3M→$129.4M3 prior comparisons
Research & development increased 20.6%
Research & development changed +20.6% from the comparable as-filed period.
$41.8M→$50.4M3 prior comparisons
Selling, general & administrative increased 15.9%
Selling, general & administrative changed +15.9% from the comparable as-filed period.
$216.6M→$251.0M3 prior comparisons
Capital expenditure decreased 7.8%
Capital expenditure changed -7.8% from the comparable as-filed period.
$44.9M→$41.4M3 prior comparisons
Cash & equivalents decreased 8.7%
Cash & equivalents changed -8.7% from the comparable as-filed period.
$315.7M→$288.1M2 prior comparisons
Inventory decreased 6.8%
Inventory changed -6.8% from the comparable as-filed period.
$1.3B→$1.2B3 prior comparisons
Operating margin moved 117 bp higher
Operating margin changed +117 basis points from the comparable as-filed period.
7.14%→8.31%3 prior comparisons
Revenue increased 7.7%
Revenue changed +7.7% from the comparable as-filed period.
$1.4B→$1.6B3 prior comparisons
Capex / revenue moved 45 bp lower
Capex / revenue changed -45 basis points from the comparable as-filed period.
3.10%→2.66%3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.